Cerity Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,061
Closed -$222K 3542
2026
Q1
$222K Buy
+7,061
New +$222K ﹤0.01% 2816
2025
Q2
Sell
-10,615
Closed -$243K 2740
2025
Q1
$243K Sell
10,615
-5,168
-33% -$125K ﹤0.01% 2124
2024
Q4
$393K Sell
15,783
-5,901
-27% -$150K ﹤0.01% 1899
2024
Q3
$541K Sell
21,684
-8,639
-28% -$256K ﹤0.01% 1738
2024
Q2
$899K Buy
30,323
+1,409
+5% +$39.1K ﹤0.01% 1273
2024
Q1
$872K Buy
+28,914
New +$802K ﹤0.01% 1342
2023
Q4
Sell
-13,682
Closed -$507K 1889
2023
Q3
$507K Sell
13,682
-3,741
-21% -$143K ﹤0.01% 977
2023
Q2
$680K Buy
17,423
+9,363
+116% +$367K ﹤0.01% 1061
2023
Q1
$294K Sell
8,060
-737
-8% -$23.3K ﹤0.01% 1536
2022
Q4
$271K Buy
+8,797
New +$273K ﹤0.01% 1188

Other funds holding RTO

Cerity Partners's RTO Position: Q2 2026 in Review

Cerity Partners sold out of Rentokil (RTO) in Q2 2026, closing a stake of 7,061 shares — an estimated $222K sold.

Cerity Partners first reported a position in RTO in Q4 2022 and held it in 10 quarters. The position peaked at $899K in Q2 2024. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Cerity Partners reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Cerity Partners sold 7,061 Rentokil shares in Q2 2026, an estimated $222K.
  • Cerity Partners first reported a position in Rentokil in Q4 2022 and held it in 10 quarters.
  • Cerity Partners's Rentokil position peaked at $899K in Q2 2024.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.